Business
Press Release Oct 29 2021
Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 29, 2021, titled "Dr. Reddy's Laboratories announces the launch of Ephedrine Sulfate Injection USP, 50 mg/mL, Single-Dose Vial in the U.S. Market".
About this update from Dr. Reddy's Laboratories Ltd.
[{"type":"text","content":" Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 29, 2021, titled \"Dr. Reddy's Laboratories announces the launch of Ephedrine Sulfate Injection USP, 50 mg/mL, Single-Dose Vial in the U.S. Market\". View Attachment","length":398,"tagName":"div"}]